KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 118 filers reported holding KITE PHARMA INC in Q4 2014. The put-call ratio across all filers is 1.96 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $3,408,000 | +277.4% | 32,877 | +185.7% | 0.04% | +218.2% |
Q1 2017 | $903,000 | +37.9% | 11,507 | -21.2% | 0.01% | +83.3% |
Q4 2016 | $655,000 | +141.7% | 14,608 | +201.4% | 0.01% | +100.0% |
Q3 2016 | $271,000 | -49.3% | 4,847 | -44.1% | 0.00% | -50.0% |
Q4 2015 | $535,000 | -3.4% | 8,675 | -12.8% | 0.01% | -25.0% |
Q3 2015 | $554,000 | +222.1% | 9,943 | +234.0% | 0.01% | +166.7% |
Q4 2014 | $172,000 | – | 2,977 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Wildcat Capital Management, LLC | 2,358,084 | $105,736,000 | 48.63% |
BAINCO INTERNATIONAL INVESTORS | 1,151,540 | $51,635,000 | 8.76% |
Coastal Bridge Advisors, LLC | 250,040 | $11,212,000 | 4.36% |
NEXTHERA CAPITAL LP | 150,000 | $6,726,000 | 3.94% |
Casdin Capital, LLC | 94,000 | $4,215,000 | 3.48% |
MENORA MIVTACHIM HOLDINGS LTD. | 1,258,899 | $56,449,000 | 2.90% |
DIALECTIC CAPITAL MANAGEMENT, LP | 85,000 | $3,812,000 | 2.14% |
SECTORAL ASSET MANAGEMENT INC | 372,223 | $16,690,000 | 1.85% |
ARK Investment Management | 97,313 | $4,364,000 | 1.59% |
BB BIOTECH AG | 800,000 | $35,872,000 | 1.33% |